Experimental drug slows progression of Alzheimer’s: Study
An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for certain patients, according to detailed data presented on Tuesday.
Published 30.11.2022 13:11